Systemic lupus erythematosus and antiphospholipid syndrome during pregnancy: Maternal and fetal complications and their management

Israel Medical Association Journal

Volumn 2, Issue 6, 2000, Pages 462-469

  Ruiz Irastorza, G ^a   Khamashta, M A ^a   Hughes, G R V ^a  

^a ST THOMAS HOSPITAL   (United Kingdom)

Author keywords

Antiphospholipid syndrome; Congenital heart block; Pregnancy; Pregnancy complications; Systemic lupus erythematosus; Thrombosis

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; ANTIHYPERTENSIVE AGENT; ANTIMALARIAL AGENT; AUTOANTIBODY; AZATHIOPRINE; CORTICOSTEROID; CYCLOSPORIN; CYTOKINE; CYTOKINE ANTIBODY; DALTEPARIN; ENOXAPARIN; HEPARIN; HYDROXYCHLOROQUINE; IMMUNOSUPPRESSIVE AGENT; LABETALOL; LOW MOLECULAR WEIGHT HEPARIN; METHYLDOPA; METHYLPREDNISOLONE; NADROPARIN; NIFEDIPINE; NONSTEROID ANTIINFLAMMATORY AGENT; PHOSPHOLIPID ANTIBODY; PREDNISOLONE; PREDNISONE; REVIPARIN; STEROID; TINZAPARIN; UNINDEXED DRUG; VITAMIN D;

ANTIPHOSPHOLIPID SYNDROME; ARTERY THROMBOSIS; DISEASE EXACERBATION; DOSE RESPONSE; FETUS DEVELOPMENT; HELLP SYNDROME; HUMAN; KIDNEY DISEASE; LOW BIRTH WEIGHT; PATIENT MONITORING; PREECLAMPSIA; PREGNANCY COMPLICATION; PREMATURITY; REVIEW; SPONTANEOUS ABORTION; SYSTEMIC LUPUS ERYTHEMATOSUS; UTERINE COMPLICATION; VEIN THROMBOSIS;

ANTIPHOSPHOLIPID SYNDROME; FEMALE; FETAL DISEASES; HUMANS; INFANT, NEWBORN; LUPUS ERYTHEMATOSUS, SYSTEMIC; PREGNANCY; PREGNANCY COMPLICATIONS;

EID: 0033839346     PISSN: 15651088     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (55)

1. Maternal T cell reactivity in pregnancy?
2. Microchimerism and the causation of scleroderma
3. Lupus pregnancy: Case-control study demonstrating absence of lupus exacerbation during or after pregnancy
4. Prospective study of pregnancy in systemic lupus erythematosus. Result of a multi disciplinary approach
5. Frequency of lupus flare in pregnancy. The Hopkins Lupus Pregnancy Center experience
6. Increased rate of lupus flare during pregnancy and the puerperium: A prospective study of 78 pregnancies
7. Lupus and pregnancy studies
8. Outcome of pregnancy in patients with systemic lupus erythematosus. A prospective study
9. Pregnancy in systemic lupus erythematosus: A prospective study
10. Pregnancy does not cause systemic lupus erythematosus to worsen
11. Pregnancy and its outcome in systemic lupus erythematosus
12. Outcome of planned pregnancies in systemic lupus erythematosus: A prospective study on 62 pregnancies
13. Systemic lupus erythematosus. VI. Analysis of the interrelationship with pregnancy
14. Pregnancy course and complications in patients with systemic lupus erythematosus
15. Systemic lupus erythematosus and pregnancy: A prospective study
16. Levels of lupus autoantibodies in pregnant SLE patients: Correlations with disease activity and pregnancy outcome
17. Obstetrical outcome of pregnancy in patients with systemic lupus erythematosus. A study of 60 cases
18. Systemic lupus erythematosus flares during pregnancy
19. Does SLE flare during pregnancy?
20. Outcome of treated pregnancies in women with antiphospholipid syndrome: An update of the Utah experience
21. A study of sixty pregnancies in patients with the antiphospholipid syndrome
22. Safety of low-molecular-weight heparin in pregnancy: A systematic review
23. Thromboprophylaxis in antiphospholipid syndrome pregnancies with previous cerebral arterial thrombotic events: Is warfarin preferable?
24. Maternal and fetal outcome in antiphospholipid syndrome pregnancies with a history of previous cerebral ischemia
25. Hopkins Lupus Pregnancy Center: 1987 to 1996
26. Obstetric outcome in systemic lupus erythematosus
27. Clinical predictors of fetal outcome in systemic lupus erythematosus
28. International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome
29. High prospective foetal loss rate in untreated pregnancies of women with current miscarriage and antiphospholipid antibodies
30. Prospective studies of the association between anticardiolipin antibody and outcome of pregnancy
31. Do low-risk pregnant women with antiphospholipid antibodies need to be treated?
32. Antiphospholipid syndrome in pregnancy: Obstetric concerns and treatment
33. Antiphospholipid antibodies and fetal death
34. Placental pathology in systemic lupus erythematosus and phospholipid antibody syndrome
35. Obstetric outcome in antiphospholipid syndrome
36. Pregnancy complications in women with recurrent miscarriage associated with antiphospholipid antibodies treated with low dose aspirin and heparin
37. Neonatal lupus syndromes
38. Neonatal lupus erythematosus
39. In utero identification and therapy of congenital heart block
40. Obstetric complications and rheumatic disease
41. The association of antiphospholipid antibodies with severe preeclampsia
42. An association between refractory HELLP syndrome and antiphospholipid antibodies during pregnancy: A report of 2 cases
43. Immunosuppressive drug use during pregnancy
44. Effects of immunosuppressive drugs during pregnancy
45. Hydroxychloroquine and lupus pregnancy: A review of a series of 36 cases
46. A randomized study of the effect of withdrawing hydroxychloroquine sulfate in systemic lupus erythematosus
47. Safety of non-steroidal anti-inflammatory drugs in pregnancy patients with rheumatic diseases
48. Repeated fetal losses associated with antiphospholipid antibodies: A collaborative randomized trial comparing prednisone with low-dose heparin
49. Comparative trial of prednisone plus aspirin versus aspirin alone in the treatment of anticardiolipin antibody-positive obstetric patients
50. Prednisone and aspirin in women with autoantibodies and unexplained recurrent fetal loss
51. Course of antiphospholipid antibodies in patients with primary antiphospholipid syndrome before, during and after pregnancy treated with low dose aspirin. Relationship of antibody levels to outcome in 7 patients
52. Antiphospholipid antibody-associated recurrent pregnancy loss: Treatment with heparin and low-dose aspirin is superior to low-dose aspirin alone
53. Randomised controlled trial of aspirin and aspirin plus heparin in pregnant women with recurrent miscarriage associated with phospholipid antibodies (or antiphospholipid antibodies)
54. Heparin therapy for pregnant women with lupus anticoagulant or anticardiolipin antibodies
55. A prospective study of fifty-three consecutive calcium heparin treated pregnancies in patients with antiphospholipid-related feta loss